Replies to post #80799 on Intellicell Biosciences Inc (fka SVFC)

[lowe6er]

http://online.barrons.com/articles/new-fda-guidance-target-cellular-therapy-1415048504


IntelliCell BioSciences ( SVFC ) has developed an autologous product called stromal vascular fraction cells. This technology uses ultrasound, rather than enzymes or agents, to separate vascular cells from a sample of adipose tissue. It then transplants them back to the donor. This process seems to fit the definitions of “autologous” and “minimally manipulated.”

L6